Association between myocardial bridge and life-threatening ventricular arrhythmia: Retrospective analysis

Impact of myocardial bridge on life-threatening ventricular arrhythmia in patients with implantable cardioverter defibrillator - Clinical significance of myocardial bridge in patients with implantable cardioverter defibrillator

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040160

Enrollment

100

Registered

2020-04-15

Start date

2019-07-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Life-threatening ventricular arrhythmia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent ICD implantation for primary or secondary prevention of sudden cardiac death at Yokohama City University Medical Center, and had analyzable coronary angiogram

Exclusion criteria

Exclusion criteria: Patients who did not have analyzable CAG images Patients with cardiac resynchronization therapy

Design outcomes

Primary

Measure	Time frame
The primary endpoint was the first episode(s) of life-threatening ventricular arrhythmia defined as appropriate ICD treatments (antitachyarrhythmia pacing and/or shock for ventricular tachycardia and/or ventricular fibrillation) or sudden cardiac death.	—

Countries

Japan

Contacts

Public ContactKozo Okada

Yokohama City University Medical Center Division of Cardiology

kokada2@yokohama-cu.ac.jp045-261-5656

Outcome results